Category: Human Interest

Commentary, Human Interest, Student Features

Putting Meaning to Masks

By Sara Chia (21S03G)

When one mentions Home-Based Learning, a shudder involuntarily comes at the reminder of all those days spent cooped up at home, with most of us spending them toiling away at our studies or getting some long-awaited rest. But while we kept ourselves occupied with that, there were heroes in our midst who were dedicating their time to lending a helping hand to the wider community.

I’m sure you must recall the time when just about everyone was frantically purchasing mask after mask to stockpile, the epitome of what Singaporeans would deem as kiasu. Unexpectedly, two childhood friends were doing the opposite — making their very own masks and selling them.

Continue reading “Putting Meaning to Masks” →
Commentary, Human Interest, Life After Raffles

Interview Feature: Alyssa Marie Loo, 2020 President’s Scholar

By Shaun Loh (21A01A), Noelle Leow (21A01B), and Samyak Jain (21S03A)
Photos courtesy of Michael Chow 

The President’s Scholarship is awarded to students who have ‘gone beyond excellence in academic pursuits and co-curricular activities to distinguish themselves’, and who have a ‘strong ethos in public service’. We conducted an interview with this year’s sole President’s Scholar, Alyssa Marie Loo, batch of 2019. Alyssa is now studying linguistics at Brown University. We also interviewed her Linguistics teacher, Ms Janissa Soh. 

Continue reading “Interview Feature: Alyssa Marie Loo, 2020 President’s Scholar” →
Commentary, Human Interest, Life After Raffles

A Researcher’s Guide: the COVID-19 Vaccine

By Arielle Yeo (21S07B) and Matthew Ethan Ramli (21S03F) 

In the global fight against the COVID-19 pandemic, the vaccine is the elixir to life as we know it. Joining Singapore’s efforts to develop it are RJC alums, Dr. Jenny Low (‘92) and Dr. Shirin Kalimuddin (‘99). As clinician-scientists at the Singapore General Hospital (SGH), they are responsible for conducting the clinical trials for the COVID-19 vaccine. Co-developed by Duke-NUS and US-based company, Arcturus Therapeutics, the vaccine has to be tested in an adaptive phase 1/2 clinical trial to ensure both its safety and efficacy. 

Continue reading “A Researcher’s Guide: the COVID-19 Vaccine” →